Mark Kiel

Mark Kiel

Company: Genomenon Inc.

Job title: Chief Scientific Officer


Fireside Chat: Harnessing the Genomics of Cancer: What Can We Learn from Orphan Drug Developers? 3:00 pm

Is it time to treat cancer as a rare disease? Meet us at the intersection of cancer and orphan drug development for a candid discussion on how evolving genomic approaches for rare diseases can help advance clinical biomarker discovery and companion diagnostics for cancer precision medicines.Read more

day: Day 1 Track C PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.